LRCX

183.27010.02%
EK

Eric K. Brandt

Independent Director

Mr. Eric K. Brandt is Independent Director of Nutanix, Inc. from May 15, 2025. He is an Independent Director of Option Care Health, Inc. from May 14, 2024. Mr. Brandt served as an Independent Director at Macerich Company since June 22, 2018 until June 2025. Mr. Brandt was the Chairman of the Board of Altaba Inc. since January 9, 2017 until 2019. He has served as a Member of the Board of Directors at Altaba since March 8, 2016. Mr. Brandt had been an Independent Director of Dentsply Sirona Inc. (formerly, Dentsply International, Inc.) since November 2, 2004 until May 22, 2024 and served as its Independent Non-Executive Chairman since September 28, 2017. Mr. Brandt had been an Independent Director at Altaba Inc. (formerly Yahoo! Inc.) since March 08, 2016 until June 2017 and has been an Independent Director of Lam Research Corporation since September 10, 2010 and served as a Director at MC10, Inc. since March 30, 2016 to February 2018. He served as the Chief Financial Officer of Broadcom Corporation from March 26, 2007 to February 1, 2016 and served as its Executive Vice President from February 2010 to February 1, 2016. Mr. Brandt served as Senior Vice President at Broadcom Corp. from March 26, 2007 to February 2010. He served as an Executive Vice President of Finance and Technical Operations and Strategy & Business/Corporate Development at Allergan, Inc. from October 2003 to September 5, 2005, President of Consumer Eye Care from 2001 to 2002, Chief Financial Officer from May 1999 to September 5, 2005 and Corporate Vice President from May 1999 to 2003. Mr. Brandt serves as a Member of the Georgia Tech President Advisory Board. From January 2001 to January 2002, he served as the President of Global Consumer Eye Care Business at Allergan. He joined Allergan, Inc. in May 1999, where he held various positions including Executive Vice President of Finance and Technical Operations and Chief Financial Officer. He served as Chief Executive Officer and President of Avanir Pharmaceuticals, Inc. from September 2005 to March 14, 2007. He spent few years with The Boston Consulting Group and held various positions in it since 1989. He served as Vice President, Partner and a Senior Member of the BCG Health Care practice. While at BCG, Mr. Brandt was involved in high level consulting engagements with top global pharmaceutical, managed care and medical device companies, focusing on corporate finance, shareholder value and post-merger integration. His professional practice included advising clients in corporate finance, marketing strategy, deal valuation, corporate development, business economics and operating performance. He has been an Independent Director of Gen Digital Inc. (formerly known as NortonLifeLock Inc.) since February 25, 2020. He served as a Director of Vertex Pharmaceuticals Incorporated from May 2003 to May 14, 2009; Matrix Pharmaceutical since December 2000 and Avanir Pharmaceuticals since September 2005 to 2007. He has been named one of the best Chief Financial Officers in America 5 times by Institutional Investor magazine. Mr. Brandt earned his Bachelor of Science Degree in Chemical Engineering from the Massachusetts Institute of Technology and a Master of Business Administration Degree from the Harvard Business School.

Positions